Refoua, Elad
Elyoseph, Zohar
Piterman, David
Geller, Alon
Meinlschmidt, Gunther
Hadar Shoval, Dorit
Article History
Received: 22 July 2025
Accepted: 4 February 2026
First Online: 20 February 2026
Declarations
:
: Not applicable. This study evaluated the performance of publicly available Generative AI models and did not involve human participants, and therefore did not require ethics approval or consent to participate.
: Not applicable This study did not involve human participants.
: Dr. Gunther Meinlschmidt (GM) received funding from various sources including the Stanley Thomas Johnson Stiftung, Gottfried und Julia Bangerter-Rhyner-Stiftung, Gesundheitsförderung Schweiz, Swiss Heart Foundation, Research Foundation of the International Psychoanalytic University (IPU) Berlin, German Federal Ministry of Education and Research, Hasler Foundation, Swiss State Secretariat for Education, Research and Innovation (SERI), and Wings Health. GM receives royalties from publishing companies as an author, including a book published by Springer. GM received an honorarium from Lundbeck for speaking at a symposium. GM is a co-founder of Therayou AG and owns stock in this company. GM is compensated for providing psychotherapy to patients, acting as a supervisor, serving as a self-experience facilitator (‘Selbsterfahrungsleiter’), and for postgraduate training of psychotherapists, psychosomatic specialists, and supervisors.Elad Refoua (ER) Dr. Zohar Elyoseph (ZE) Dr. Dorit Hadar-Shoval (DH) David Piterman (DP) and Alon Geller (AG) have declared no competing interests.
: Not applicable. This study is not a clinical trial and did not require registration.